Clinical Trial: Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Histological Characterization and Differentiation of Rash From Other EGFR Inhibitors

Brief Summary: The purpose of this study is to characterize the microscopic findings of skin rash associated with the use of chemotherapeutic anticancer agents known as epidermal growth factor inhibitors (EGFRIs).